Phosphorus Fertilizers from Sewage Sludge Ash and Animal Blood as an Example of Biobased Environment-Friendly Agrochemicals: Findings from Field Experiments.

Wastes of biological origin from wastewater treatment systems and slaughterhouses contain substantial amounts of phosphorus (P) with high recovery potential and can contribute to alleviating the global P supply problem. This paper presents the performance of fertilizer (AF) and biofertilizer (BF) from sewage sludge ash and animal blood under field conditions. BF is AF incorporated with lyophilized cells of P-solubilizing bacteria, Bacillus megaterium. In the experiments with spring or winter wheat, the biobased fertilizers were compared to commercial P fertilizer, superphosphate (SP). No P fertilization provided an additional reference. Fertilizer effects on wheat productivity and on selected properties of soil were studied. BF showed the same yield-forming efficiency as SP, and under poorer habitat conditions, performed slightly better than AF in increasing yield and soil available P. Biobased fertilizers applied at the P rate up to 35.2 kg ha-1 did not affect the soil pH, did not increase As, Cd, Cr, Ni, and Pb content, and did not alter the abundance of heterotrophic bacteria and fungi in the soil. The findings indicate that biobased fertilizers could at least partially replace conventional P fertilizers. Research into strain selection and the proportion of P-solubilizing microorganisms introduced into fertilizers should be continued.

Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.

TLR9 recognizes unmethylated CpG-rich, pathogen-derived DNA sequences and represents the component of the innate immune system that heavily influences adaptive immunity and may contribute to the immunological disturbances in rheumatoid arthritis (RA). Accumulating data indicate that BM of RA patients participates in the pathogenesis of this disease as a site of proinflammatory cytokines overproduction and lymphocytes activation. Here, we investigated the functionality of TLR9 and its role in the modulation of RA BM B-cell functions. We report that BM B cells isolated from RA patients express TLR9 at the mRNA and protein levels acquired at the stage of preB/immature B-cell maturation. Stimulation of BM CD20(+) B cells by CpG-containing oligodeoxynucleotide-enhanced expression of activation markers (CD86 and CD54) triggered IL-6 and TNF-alpha secretion and cell proliferation. Significantly higher levels of eubacterial DNA encoding 16S-rRNA were found in BM samples from RA than osteoarthritis patients. Moreover, RA BM B cells exerted higher expression of CD86 than their osteoarthritis counterparts, suggesting their in situ activation via TLR9. Thus, our data indicate that TLR9 may participate in direct activation and proliferation of B cells in BM, and therefore could play a role in the pathogenesis of RA.